Ependymoma Global Clinical Trials Review, H2, 2016

Ependymoma Global Clinical Trials Review, H2, 2016


  • Products Id :- GDHC3736CTIDB
  • |
  • Pages: 114
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ependymoma Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, "Ependymoma Global Clinical Trials Review, H2, 2016" provides an overview of Ependymoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ependymoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Central and South America 12

Clinical Trials by G7 Countries: Proportion of Ependymoma to Oncology Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Ependymoma to Oncology Clinical Trials 16

Clinical Trials by Phase in E7 Countries 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Clinical Trials by End Point Status 21

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Top Companies Participating in Ependymoma Therapeutics Clinical Trials 25

Prominent Drugs 27

Clinical Trial Profile Snapshots 28

Appendix 111

Abbreviations 111

Definitions 111

Research Methodology 112

Secondary Research 112

About GlobalData 113

Contact Us 113

Disclaimer 113

Source 114

List of Figures

Ependymoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Ependymoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ependymoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ependymoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9

Ependymoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Ependymoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Ependymoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 12

Proportion of Ependymoma to Oncology Clinical Trials, G7 Countries (%), 2016* 13

Ependymoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

Ependymoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of Ependymoma to Oncology Clinical Trials, E7 Countries (%), 2016* 16

Ependymoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Ependymoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18

Ependymoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 19

Ependymoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20

Ependymoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21

Ependymoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22

Ependymoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 23

Ependymoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24

Ependymoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25

Ependymoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

GlobalData Methodology 112

List of Tables

Ependymoma Therapeutics, Global, Clinical Trials by Region, 2016* 6

Ependymoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ependymoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ependymoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9

Ependymoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Ependymoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Ependymoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12

Proportion of Ependymoma to Oncology Clinical Trials, G7 Countries (%), 2016* 13

Ependymoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

Ependymoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of Ependymoma to Oncology Clinical Trials, E7 Countries (%), 2016* 16

Ependymoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Ependymoma Therapeutics, Global, Clinical Trials by Phase, 2016* 18

Ependymoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 19

Ependymoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20

Ependymoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21

Ependymoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22

Ependymoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 23

Ependymoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24

Ependymoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

Ependymoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Children's Cancer and Leukaemia Group

F. Hoffmann-La Roche Ltd.

INC Research Holdings, Inc.

AstraZeneca Plc

Astellas Pharma Inc.

AbbVie Inc

Burzynski Research Institute, Inc.

Axelar AB

Agennix AG

Advantagene, Inc.

select a license

Single User License
USD 2500 INR 168625
Site License
USD 5000 INR 337250
Corporate User License
USD 7500 INR 505875

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com